$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Telisotuzumab-EMRELIS is developed and produced by which company and drug qualification description
2026-02-01 22:25:32
Check Details
Analysis of whether tovorafenib has been included in medical insurance and the reimbursement policy and cost description in 2025
2026-02-01 22:25:32
Check Details
Where can I buy vorasidenib-VORANIGO at home and abroad?
2026-02-01 22:25:32
Check Details
Detailed analysis of Zongatinib (Zongatinib) price and drug purchase channel reference information
2026-02-01 22:25:32
Check Details
An analysis of vosoritide’s domestic and overseas marketing dynamics, clinical progress and R&D updates
2026-02-01 22:25:32
Check Details
Interpretation of the main diseases treated by Mecobalamin and its neurological-related indications
2026-02-01 22:25:32
Check Details
Whether cobimetinib (cobimetinib) has been included in medical insurance and details of the 2025 reimbursement policy
2026-02-01 22:25:32
Check Details
Latest market price and medical insurance reimbursement policy updates for macitentan in 2025
2026-02-01 22:25:32
Check Details
Is Tilorisen (Harcos) tablets or capsules? Differences between different dosage forms and instructions on how to take them
2026-02-01 22:25:32
Check Details
Comprehensive explanation of how to take Pretomanid and medication recommendations for different patients
2026-02-01 22:25:32
Check Details
The latest market price of voclosporin in 2025 and reference drug purchase information in pharmacies in various regions
2026-02-01 22:25:32
Check Details
The complete version of the official instructions and precautions for ponatinib
2026-02-01 22:25:32
Check Details
1
2
...
2255
2256
2257
2258
2259
2260
2261
...
10213
10214
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Olutasidenib (Rezlidhia): A Targeted Drug for IDH1-Mutated Relapsed/Refractory AML
2
Capmatinib Redefines Precision Therapy for MET-Mutated Lung Cancer
3
FDA Approves Dual Immunotherapy Combo: Tecvayli + Darzalex Faspro Transforms RRMM Treatment
4
Cabozantinib: Pivotal Advancements and Global Implications in Multi-Cancer Treatment with Multi-Kinase Inhibition
5
Pretomanid for Drug-Resistant TB: Risks and Management of 3-Year Treatment
6
SKYSCRAPER-02C Study: New Hope for Extensive-Stage Small Cell Lung Cancer Treatment
7
LPCAT3: The Key Player in MASH Progression to Hepatocellular Carcinoma
8
Tucatinib (Tukysa): A Precision Medicine for HER2-Positive Breast & Colorectal Cancer
9
Venetoclax Therapy Guidelines: Balancing Precision Targeting with Risk Management
10
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers
11
A Comprehensive Guide to Benralizumab Adverse Reactions: Prevention and Management
12
Lemborexant: A Dual Orexin Receptor Antagonist Revolutionizing Insomnia Treatment